JAVMA news
Merial closer to restoring full supply of Immiticide
Merial has found an alternative source for the active ingredient in Immiticide, a treatment for canine heartworm disease
JAVMA news
Florida pharmacy accused of illegal compounding
Federal authorities want to stop bulk animal drug compounding by a Florida company that produced a compound connected with the April 2009 deaths of 21…
JAVMA news
Welfare policies revised and adopted
The AVMA has revised several of its food animal welfare policies and adopted a policy concerning the use of electromuscular disruption devices (eg,…
JAVMA news
Extralabel drug substitution runs afoul of law
Extralabel use of drugs can give veterinarians effective options in treating patients, but there are limitations veterinarians should be aware of when…
JAVMA news
Rinderpest nearly eradicated worldwide
A disease that killed millions of cattle and contributed to the development of modern veterinary medicine could soon be the first animal disease…
JAVMA news
FDA targets medication errors resulting from unclear abbreviations
The Food and Drug Administration and Institute for Safe Medication Practices are campaigning to reduce medication errors resulting from unclear…
JAVMA news
Staying relevant in cattle care
The dean at the Iowa State University College of Veterinary Medicine is particularly concerned that veterinarians have not generated data that…
JAVMA news
Company issues warning about meloxicam in cats
Boehringer Ingelheim Vetmedica is adding a boxed warning about use of Metacam in cats to the product's labeling. Metacam is the company's brand-name…
AVMA news
Sales, distribution of medically important antimicrobials remain down for food animals
Annual sales and distribution by volume of medically important antimicrobials for food-producing animals remain down since the substantial decrease in…
AVMA news
Honeybee vaccine receives conditional license from USDA
The U.S. Department of Agriculture has granted a conditional license for a vaccine to protect honeybees against American foulbrood. The only…
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
AVMA news
Remaining medically important antimicrobials transitioning to prescription status
The Food and Drug Administration is reminding stakeholders that certain over-the-counter antimicrobial products for animals are transitioning to…
AVMA news
New law clarifies alternatives to animal testing for safety, efficacy of drugs
The recently passed FDA Modernization Act 2.0 authorizes the use of certain alternatives to animal testing, including cell-based assays and computer…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
AVMA news
AVMA testifies in support of improving new animal drug review efficiency
AVMA President Lori Teller appeared before a House subcommittee to urge reauthorization of legislation supporting approval of new and generic animal…
AVMA news
Symposium explores psychological impacts of euthanasia, depopulation
Speakers at the AVMA Humane Endings Symposium, held January 26-29 in Chicago, shared their personal experiences with depopulation of cattle and sheep…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
AVMA news
EPA, FDA weigh oversight overhaul for animal parasite products
Two federal agencies are considering transferring oversight of some 600 products from the Environmental Protection Agency (EPA) to the Food and Drug…
AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…
AVMA news
Canine parvovirus treatment receives conditional approval
The U.S. Department of Agriculture has granted a conditional license for the Canine Parvovirus Monoclonal Antibody—Elanco's first monoclonal antibody…
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…
AVMA news
Convention sessions, statement touch on environmental impact of veterinary medicine
Speakers at AVMA Convention 2023 will talk about the impacts of climate change and how environmental sustainability is an increasingly important topic…